Immunogenomics and proteomics in hematopoietic stem cell transplantation: predicting post-hematopoietic stem cell transplant complications.
Weissinger
Eva M
EM
Hannover Medical School, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Carl-Neuberg-Str.1, 30625 Hannover, Germany. mischak-weissinger.eva@mh-hannover.de
Dickinson
Anne M
AM
D000486:Allergy and Immunology; D016207:Cytokines / Q000378:metabolism; D023281:Genomics / Q000379:methods*; D005838:Genotype; D006086:Graft vs Host Disease / Q000209:etiology; D006680:HLA Antigens / Q000378:metabolism; D019337:Hematologic Neoplasms / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods*; D006801:Humans; D007113:Immunity, Innate; D016130:Immunophenotyping / Q000379:methods; D008954:Models, Biological; D040901:Proteomics / Q000379:methods; D019172:Transplantation Conditioning; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D016207:Cytokines; D006680:HLA Antigens; D014409:Tumor Necrosis Factor-alpha